Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
One study found that the intraperitoneal administration of BPC-157 counteracted the effects of MTPT, an agent used to induce damage caused by Parkinsons disease
By operating our own laboratory, we maintain complete, end-to-end control over the synthesis, manufacturing, and analytical testing of every single compound
These people have always returned my emails & calls
Expiry: September 2027
BPC 157 is a peptide, not a steroid
A standard 80 mg KLOW vial contains 50 mg GHK-Cu and 10 mg each of BPC-157, TB-4, and KPV
US$ 26.32
US$ 22.30
US$ 22.49
US$ 26.91
